Spatial omics technologies for understanding molecular status associated with cancer progression
Cancer Science · 2024-10 · 115 (10) · 3208-3217
DOI: 10.1111/cas.16283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 23.07.2024. Verfasst von Satoi Nagasawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Disease Progression, Genomics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Cancer cells are generally exposed to numerous extrinsic stimulations in the tumor microenvironment. In this environment, cancer cells change their expression profiles to fight against circumstantial stresses, allowing their progression in the challenging tissue space. Technological advancements of spatial omics have had substantial influence on cancer genomics. This technical progress, especially that occurring in the spatial transcriptome, has been drastic and rapid. Here, we describe the latest spatial analytical technologies that have allowed omics feature characterization to retain their spatial and histopathological information in cancer tissues. Several spatial omics platforms have been launched, and the latest platforms finally attained single‐cell level or even higher subcellular level resolution. We discuss several key papers elucidating the initial utility of the spatial analysis. In fact, spatial transcriptome analyses reveal comprehensive omics characteristics not only in cancer cells but also their surrounding cells, such as tumor infiltrating immune cells and cancer‐associated fibroblasts. We also introduce several spatial omics platforms. We describe our own attempts to investigate molecular events associated with cancer progression. Furthermore, we discuss the next challenges in analyzing the multiomics status of cells, including their morphology and location. These novel technologies, in conjunction with spatial transcriptome analysis and, more importantly, with histopathology, will elucidate even novel key aspects of the intratumor heterogeneity of cancers. Such enhanced knowledge is expected to open a new path for overcoming therapeutic resistance and eventually to precisely stratify patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
ORCID-Profile: Ayako Suzuki
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Nagasawa, S., Zenkoh, J., Suzuki, Y., & Suzuki, A. (2024). Spatial omics technologies for understanding molecular status associated with cancer progression. Cancer Science, 115(10), 3208-3217. https://doi.org/10.1111/cas.16283
Vancouver
Nagasawa S, Zenkoh J, Suzuki Y, Suzuki A. Spatial omics technologies for understanding molecular status associated with cancer progression. Cancer Science. 2024;115(10):3208-3217. doi:10.1111/cas.16283
BibTeX
@article{Nagasawa2024,
author = {Nagasawa, Satoi and Zenkoh, Junko and Suzuki, Yutaka and Suzuki, Ayako},
title = {Spatial omics technologies for understanding molecular status associated with cancer progression},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {10},
pages = {3208--3217},
doi = {10.1111/cas.16283}
}
EUVIMED